All Work

Chris Lange

Why AcelRx Is Jumping Despite FDA Update

AcelRx shares made a solid gain on Wednesday despite a less-than-favorable update from the FDA. However, there is a vote for approval on Friday. and that seems to be what investors are optimistic about.

Chris Lange · 8 years ago

Short Sellers Run for Cover From Major Pharma

The September 28 short interest data have been compared with the previous figures, and short interest in these selected pharmaceutical stocks decreased.

Chris Lange · 8 years ago

Cybersecurity Stocks Scare Off Short Sellers

The September 28 short interest data have been compared with the previous figures, and short interest in most of these selected cybersecurity stocks decreased.

Chris Lange · 8 years ago

Short Sellers Back Off Major Biotechs

The September 28 short interest data have been compared with the previous report, and short interest in most of the selected biotech stocks decreased.

Chris Lange · 8 years ago

Tuesday’s Biggest Winners and Losers in the S&P 500

Tuesday was a relatively flat day for the broad U.S. markets. The broad markets have been slowing down over the last few trading days as a result of increased strength in the bond markets.…

Chris Lange · 8 years ago

Why PPG Shares Are Sliding

PPG Industries shares dropped on Tuesday after the company announced preliminary results for its third quarter. The expectations fell somewhat short, and inflation, as well as rising costs, are to blame for this.

Chris Lange · 8 years ago

Aurora Cannabis Gears Up for IPO

Aurora Cannabis, one of the world's largest and leading cannabis companies, has filed with the SEC in preparation for its initial public offering.

Chris Lange · 8 years ago

Can This New Board Member Help Save Sears?

Sears shares slid slightly after the company announced its newest addition to the board of directors, an advisor with experience in organizational change.

Chris Lange · 8 years ago

Can This Clinical Hold Stop Affimed’s Momentum?

Affimed shares took a big step back early on Tuesday after the company announced that it has placed its AFM11 on clinical hold, and has notified the global health authorities of its decision.

Chris Lange · 8 years ago

Exelixis Initiates Key Late-Stage Cancer Trial

Exelixis shares dipped on Monday after the company announced that it has initiated a late-stage trial in patients with radioiodine-refractory differentiated thyroid cancer (DTC).

Chris Lange · 8 years ago

Starbucks Announces Big Changes at the Top

Starbucks shares didn’t react much despite the coffee giant announcing a big change at the top. The company is appointing a new CFO who will be taking over at the end of November.

Chris Lange · 8 years ago